Background: Periprosthetic joint infection (PJI) remains a devastating complication of joint arthroplasty. Although intraoperative frozen section histology (> 5 neutrophils/HPF) is incorporated into the 2018 MSIS diagnostic criteria, its prognostic value for predicting postoperative PJI remains controversial.
Methods: Primary or revision THA/TKA procedures in our hospital between January 1, 2015 and December 31, 2021 with intraoperative frozen section histologic results were eligible for inclusion. Association between intraoperative frozen section histology and postoperative PJI was investigated based on the medical records, and a similar analysis of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) was also performed.
Results: A total of 14,969 knee/hip procedures were identified. After case selection, 797 cases comprising 529 (66.4%) primary and 268 (33.6%) revision were included. According to our data, frozen section positivity showed no PJI association, both in primary (OR, 1.206 [95% CI, 0.133–10.914], P > 0.999) and revision procedures (OR, 1.287 [95% CI, 0.331–5.007], p = 0.717). Conversely, elevated CRP (OR, 15.196 [95% CI, 1.916–120.523], p = 0.001) and ESR (OR, 5.794 [95% CI, 1.4979–22.4129], p = 0.008) predicted PJI exclusively in revisions.
Conclusions: Therefore, isolated positive frozen section results should not be the sole basis for surgical strategy. Elevated CRP/ESR levels during revision surgery warrant heightened vigilance and consideration of extended anti-infective treatment.
Level of Evidence: III.
| [1] |
E. Lenguerrand, M. R. Whitehouse, A. D. Beswick, et al., “Risk Factors Associated With Revision for Prosthetic Joint Infection After Hip Replacement: A Prospective Observational Cohort Study,” Lancet Infectious Diseases 18, no. 9 (2018): 1004–1014.
|
| [2] |
S. M. Kurtz, E. Lau, J. Schmier, K. L. Ong, K. Zhao, and J. Parvizi, “Infection Burden for Hip and Knee Arthroplasty in the United States,” Journal of Arthroplasty 23, no. 7 (2008): 984–991.
|
| [3] |
W. V. Probasco, C. Cefalu, Jr., R. Lee, D. Lee, A. Gu, and V. Dasa, “Prevalence of Idiopathically Elevated ESR and CRP in Patients Undergoing Primary Total Knee Arthroplasty as a Function of Body Mass Index,” Journal of Clinical Orthopaedics and Trauma 11, no. Suppl 5 (2020): S722–S728.
|
| [4] |
H. A. Backe, Jr., D. A. Wolff, and R. E. Windsor, “Total Knee Replacement Infection After 2-Stage Reimplantation: Results of Subsequent 2-Stage Reimplantation,” Clinical Orthopaedics and Related Research 331 (1996): 125–131.
|
| [5] |
A. J. Moore, A. W. Blom, M. R. Whitehouse, and R. Gooberman-Hill, “Deep Prosthetic Joint Infection: A Qualitative Study of the Impact on Patients and Their Experiences of Revision Surgery,” BMJ Open 5, no. 12 (2015): e009495.
|
| [6] |
A. Dombrowky, J. Jolissaint, S. L. Posey, et al., “Regional Periprosthetic Joint Infection Centers: The Time Has Come for a Paradigm Change in the Treatment of Periprosthetic Joint Infection,” Journal of Arthroplasty 39, no. 12 (2024): 2887–2892.
|
| [7] |
A. Patel, G. Pavlou, R. E. Mujica-Mota, and A. D. Toms, “The Epidemiology of Revision Total Knee and Hip Arthroplasty in England and Wales: A Comparative Analysis With Projections for the United States. A Study Using the National Joint Registry Dataset,” Bone & Joint Journal 97, no. B-8 (2015): 1076–1081.
|
| [8] |
E. W. Paxton, O. Furnes, R. S. Namba, M. C. Inacio, A. M. Fenstad, and L. I. Havelin, “Comparison of the Norwegian Knee Arthroplasty Register and a United States Arthroplasty Registry,” Journal of Bone and Joint Surgery. American Volume 93, no. Suppl 3 (2011): 20–30.
|
| [9] |
J. W. Kennedy, R. Sinnerton, G. Jeyakumar, N. Kane, D. Young, and R. M. D. Meek, “Periprosthetic Joint Infection of the Hip,” Bone & Joint Journal 106, no. B-8 (2024): 802–807.
|
| [10] |
S. K. Kunutsor, M. R. Whitehouse, A. W. Blom, A. D. Beswick, and Team I, “Patient-Related Risk Factors for Periprosthetic Joint Infection After Total Joint Arthroplasty: A Systematic Review and Meta-Analysis,” PLoS One 11, no. 3 (2016): e0150866.
|
| [11] |
C. Xu, H. Guo, P. Qu, J. Fu, F. C. Kuo, and J. Y. Chen, “Preoperatively Elevated Serum Inflammatory Markers Increase the Risk of Periprosthetic Joint Infection Following Total Knee Arthroplasty in Patients With Osteoarthritis,” Therapeutics and Clinical Risk Management 14 (2018): 1719–1724.
|
| [12] |
S. Ghosh, S. Paul, D. P. Bhattacharjee, P. Ghosh, and N. Chatterjee, “Prognostic Value of Baseline High-Sensitivity C-Reactive Protein in Patients Undergoing Replacement Arthroplasty,” JNMA; Journal of the Nepal Medical Association 48-174 (2009): 144–148.
|
| [13] |
G. L. Ackland, J. M. Scollay, R. W. Parks, I. de Beaux, and M. G. Mythen, “Pre-Operative High Sensitivity C-Reactive Protein and Postoperative Outcome in Patients Undergoing Elective Orthopaedic Surgery,” Anaesthesia 62, no. 9 (2007): 888–894.
|
| [14] |
G. Bori, A. Soriano, S. Garcia, C. Mallofre, J. Riba, and J. Mensa, “Usefulness of Histological Analysis for Predicting the Presence of Microorganisms at the Time of Reimplantation After Hip Resection Arthroplasty for the Treatment of Infection,” Journal of Bone and Joint Surgery. American Volume 89, no. 6 (2007): 1232–1237.
|
| [15] |
C. J. Della Valle, E. Bogner, P. Desai, et al., “Analysis of Frozen Sections of Intraoperative Specimens Obtained at the Time of Reoperation After Hip or Knee Resection Arthroplasty for the Treatment of Infection,” Journal of Bone and Joint Surgery. American Volume 81, no. 5 (1999): 684–689.
|
| [16] |
J. George, G. Kwiecien, A. K. Klika, et al., “Are Frozen Sections and MSIS Criteria Reliable at the Time of Reimplantation of Two-Stage Revision Arthroplasty?,” Clinical Orthopaedics and Related Research 474, no. 7 (2016): 1619–1626.
|
| [17] |
J. Parvizi, T. L. Tan, K. Goswami, et al., “The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria,” Journal of Arthroplasty 33, no. 5 (2018): 1309-14 e2.
|
| [18] |
H. Wittkowski, D. Foell, E. af Klint, et al., “Effects of Intra-Articular Corticosteroids and Anti-TNF Therapy on Neutrophil Activation in Rheumatoid Arthritis,” Annals of the Rheumatic Diseases 66, no. 8 (2007): 1020–1025.
|
| [19] |
M. Kataoka, T. Torisu, H. Tsumura, S. Yoshida, and M. Takashita, “An Assessment of Histopathological Criteria for Infection in Joint Arthroplasty in Rheumatoid Synovium,” Clinical Rheumatology 21, no. 2 (2002): 159–163.
|
| [20] |
N. Dalbeth, A. L. Gosling, A. Gaffo, and A. Abhishek, “Gout,” Lancet (London, England) 397-10287 (2021): 1843–1855.
|
| [21] |
F. Zhang, Y. Xia, J. Su, et al., “Neutrophil Diversity and Function in Health and Disease,” Signal Transduction and Targeted Therapy 9, no. 1 (2024): 343.
|
| [22] |
S. Ahmadi, T. M. Lawrence, B. F. Morrey, and J. Sanchez-Sotelo, “The Value of Intraoperative Histology in Predicting Infection in Patients Undergoing Revision Elbow Arthroplasty,” Journal of Bone and Joint Surgery. American Volume 95, no. 21 (2013): 1976–1979.
|
| [23] |
J. Straub, K. Staats, K. Vertesich, L. Kowalscheck, R. Windhager, and C. Bohler, “Two-Stage Revision for Periprosthetic Joint Infection After Hip and Knee Arthroplasty,” Bone & Joint Journal 106-B-4 (2024): 372–379.
|
| [24] |
G. Kwiecien, J. George, A. K. Klika, Y. Zhang, T. W. Bauer, and C. A. Rueda, “Intraoperative Frozen Section Histology: Matched for Musculoskeletal Infection Society Criteria,” Journal of Arthroplasty 32, no. 1 (2017): 223–227.
|
| [25] |
B. J. McGrory and M. W. Becker, “Screening for Infection to Determine Treatment in Second-Stage Reimplantation of Total Knee Prostheses,” Journal of Bone and Joint Surgery. American Volume 83, no. 9 (2001): 1433.
|
| [26] |
M. J. Kraay, V. M. Goldberg, S. J. Fitzgerald, and M. J. Salata, “Cementless Two-Staged Total Hip Arthroplasty for Deep Periprosthetic Infection,” Clinical Orthopaedics and Related Research 441 (2005): 243–249.
|
| [27] |
M. E. Kelly, S. R. Bahethi, M. E. King, B. C. Elstner, J. J. Turcotte, and P. J. King, “The Utility of Frozen Section Histology in Diagnosing Periprosthetic Joint Infection in Revision Total Joint Arthroplasty,” Journal of Arthroplasty 36, no. 6 (2021): 2137–2143.
|
| [28] |
G. Maoz, M. Phillips, J. Bosco, et al., “The Otto Aufranc Award: Modifiable Versus Nonmodifiable Risk Factors for Infection After Hip Arthroplasty,” Clinical Orthopaedics and Related Research 473, no. 2 (2015): 453–459.
|
| [29] |
J. M. Mirra, H. C. Amstutz, M. Matos, and R. Gold, “The Pathology of the Joint Tissues and Its Clinical Relevance in Prosthesis Failure,” Clinical Orthopaedics and Related Research 117 (1976): 221–240.
|
| [30] |
G. L. Burn, A. Foti, G. Marsman, D. F. Patel, and A. Zychlinsky, “The Neutrophil,” Immunity 54, no. 7 (2021): 1377–1391.
|
| [31] |
N. A. Hodges, E. M. Sussman, and J. P. Stegemann, “Aseptic and Septic Prosthetic Joint Loosening: Impact of Biomaterial Wear on Immune Cell Function, Inflammation, and Infection,” Biomaterials 278 (2021): 121127.
|
| [32] |
F. Martinon, V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp, “Gout-Associated Uric Acid Crystals Activate the NALP3 Inflammasome,” Nature 440-7081 (2006): 237–241.
|
| [33] |
Y. He, H. Hara, and G. Nunez, “Mechanism and Regulation of NLRP3 Inflammasome Activation,” Trends in Biochemical Sciences 41, no. 12 (2016): 1012–1021.
|
| [34] |
X. Xie, P. Wang, M. Jin, et al., “IL-1beta-Induced Epithelial Cell and Fibroblast Transdifferentiation Promotes Neutrophil Recruitment in Chronic Rhinosinusitis With Nasal Polyps,” Nature Communications 15-1 (2024): 9101.
|
| [35] |
Y. Cai, H. Hu, Y. Chen, et al., “Staphylococcus aureus Manipulates Osteocytes to Cause Persistent Chronic Osteomyelitis and Antibiotic Resistance via Pyroptosis Pathway Suppression,” Drug Resistance Updates 84 (2026): 101295.
|
| [36] |
M. D. Smith, “The Normal Synovium,” Open Rheumatology Journal 5 (2011): 100–106.
|
| [37] |
G. Godoy, G. Sumarriva, J. L. Ochsner, Jr., et al., “Preoperative Acute Inflammatory Markers as Predictors for Postoperative Complications in Primary Total Knee Arthroplasty,” Ochsner Journal 16, no. 4 (2016): 481–485.
|
| [38] |
C. R. Scanzello, “Role of Low-Grade Inflammation in Osteoarthritis,” Current Opinion in Rheumatology 29, no. 1 (2017): 79–85.
|
| [39] |
H. L. Wright, R. J. Moots, R. C. Bucknall, and S. W. Edwards, “Neutrophil Function in Inflammation and Inflammatory Diseases,” Rheumatology (Oxford, England) 49, no. 9 (2010): 1618–1631.
|
| [40] |
J. Schmolders, S. Koob, P. Schepers, et al., “Lower Limb Reconstruction in Tumor Patients Using Modular Silver-Coated Megaprostheses With Regard to Perimegaprosthetic Joint Infection: A Case Series, Including 100 Patients and Review of the Literature,” Archives of Orthopaedic and Trauma Surgery 137, no. 2 (2017): 149–153.
|
| [41] |
Prophylactic Antibiotic Regimens in Tumor Surgery I, M. Ghert, P. Schneider, et al., “Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial,” JAMA Oncology 8, no. 3 (2022): 345–353.
|
Rights & permissions
2026 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
PDF
(505KB)
